Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00414856
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2006-12-21
Brief Title:
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multi-Center Randomized Double-Blind Placebo- and Positive-Control Double-Dummy 3 Parallel Cohort Two-Way Crossover Single Oral Dose Study in GERD Gastro Esophageal Reflux Disease Patients to Evaluate the Effects of AFQ056 and Baclofen Positive Control on the Incidence of Meal-Induced Gastro Esophageal Reflux Events
Status:
COMPLETED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety and tolerability of oral single dose applications of AFQ056 in GERD patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None